France· FR:65168309
MIANSERINE TEVA 60 mg, comprimé pelliculé sécable
A mianserin product containing chlorhydrate de miansérine, registered in France by TEVA SANTE, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Mianserin is registered in 15 of 19 countries.
Countries holding a registration under ATC N06AX03 (mianserin), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 9 of them publish a price we can compare per daily dose
Mianserin · ATC N06AX03
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of mianserin costs, country by country.
Normalised to the WHO defined daily dose (60 mg), the median price runs from $0.32 in France to $1.15 in Switzerland — a ×3.6 gap.
- France: $0.32 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Mianserin · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.15
- IT Italy$0.68
- FR France$0.32
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE MIANSÉRINE
- Manufacturer
- TEVA SANTE
- Country
- France (FR)
- ATC code
- N06AX03
- ATC class
- Mianserin
- Defined daily dose
- 60 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400936144705plaquette(s) PVC-Aluminium de 14 comprimé(s)EUR 2.7
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
19 interactions on record for mianserin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mianserin · interactions on record
19 records
19 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Mianserin in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandMiaxanOrion Corporation Orion Pharma
- SwitzerlandMianserin-Mepha 60 mg, FilmtablettenMepha Pharma AG
- PolandDeprexoletAdamed Pharma S.A.
- SwedenMianserin Ebb 60 mg Filmdragerad tablettEbb Medical AB
- United KingdomMianserin 10mg tabletsKent Pharma (UK) Ltd
- CzechiaLERIVONN.V. Organon, Oss
- BelgiumLerivon 10 mgOrganon Belgium
- NorwayMianserin holstenNeuraxpharm
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Mianserin Viatris, Tolvon
- Belgium · Lerivon
- Cyprus · Mianserin Remedica
- Czechia · Lerivon
- Germany · Mianserin, Mianserin Neuraxpharm
- Denmark · Mianserin Orifarm, Mianserin Viatris
- Spain · Lantanon
- Finland · Tolvon
- United Kingdom (Northern Ireland) · Mianserin Generics Uk
- Hungary · Miagen
- Iceland · Mianserin Mylan
- Italy · Lantanon
- Luxembourg · Lerivon
- Malta · Mianserin Remedica
- Netherlands · Tolvon
- Norway · Mianserin Viatris
- Poland · Deprexolet, Lerivon
- Portugal · Tolvon
- Sweden · Mianserin Viatris
- Slovakia · Lerivon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa1d0b3e-5ff2-45cb-a444-f74898e08106 GET /v1/drugs/fa1d0b3e-5ff2-45cb-a444-f74898e08106?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65168309",
"date_amm": "2001-07-06",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CHLORHYDRATE DE MIANSÉRINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé sécable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about mianserin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.